Shoulder Innovations SI
NYSE SI
$19.79 -0.20 (-1.00%)
As of: Sep 9, 2026 · 11:18 AM EDT

Shoulder Innovations (SI) Preferred Stock Liabilities (2024 - 2025)

Shoulder Innovations' (SI) quarterly Preferred Stock Liabilities came in at $126.7 million in Q2 2025, up 70.12% on a YoY basis from $74.5 million in Q2 2024, and up 34.58% quarter-over-quarter from $94.1 million in Q1 2025.

Analysis

Shoulder Innovations (SI) Preferred Stock Liabilities (2024 - 2025) Analysis & Trends

Shoulder Innovations (SI) has reported Preferred Stock Liabilities for 2 consecutive years, with $126.7 million the latest figure, recorded in Q2 2025.

  • For the quarter ending Q2 2025, Preferred Stock Liabilities rose 70.12% year-over-year to $126.7 million; the trailing twelve-month figure through Jun 2025 stood at $126.7 million (up 70.12% YoY), and the FY2024 full-year result was $74.5 million, changed N/A from the prior year.
  • Preferred Stock Liabilities climbed to $126.7 million in Q2 2025 per SI's latest filing, from $94.1 million in the prior quarter.
  • Across five years, Preferred Stock Liabilities topped out at $126.7 million in Q2 2025 and bottomed at $74.5 million in Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Abbott Laboratories 185.05 Bn 179.45 Bn 7.27 Bn -
2 Intuitive Surgical 124.43 Bn 119.22 Bn 1.96 Bn -
3 Medtronic 118.52 Bn 109.70 Bn 6.34 Bn -
4 Stryker 104.55 Bn 101.07 Bn 4.50 Bn -
5 Boston Scientific 67.11 Bn 66.57 Bn 3.85 Bn -
6 Edwards Lifesciences 49.85 Bn 45.60 Bn 1.35 Bn -
7 Alcon 33.97 Bn 32.52 Bn 1.68 Bn -
8 Dexcom 32.28 Bn 30.33 Bn 830.00 Mn -
9 Steris 21.15 Bn 20.67 Bn 684.20 Mn -
10 Shoulder Innovations 413.68 Mn 314.68 Mn 13.44 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 126.70 Mn
Mar 31, 2025 94.15 Mn
Dec 31, 2024 74.48 Mn
Sep 30, 2024 74.48 Mn
Jun 30, 2024 74.48 Mn